409 related articles for article (PubMed ID: 34445171)
1. Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of
Giong HK; Subramanian M; Yu K; Lee JS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445171
[TBL] [Abstract][Full Text] [Related]
2.
Pir GJ; Choudhary B; Mandelkow E
FASEB J; 2017 Dec; 31(12):5137-5148. PubMed ID: 29191965
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
5. Studying tauopathies in Drosophila: A fruitful model.
Sun M; Chen L
Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
[TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative tauopathy in the worm.
Goedert M
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9653-5. PubMed ID: 12913116
[No Abstract] [Full Text] [Related]
7. Zebrafish models of Tauopathy.
Bai Q; Burton EA
Biochim Biophys Acta; 2011 Mar; 1812(3):353-63. PubMed ID: 20849952
[TBL] [Abstract][Full Text] [Related]
8. Transgenic animal models of tauopathies.
Lee VM; Kenyon TK; Trojanowski JQ
Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
[TBL] [Abstract][Full Text] [Related]
9. Potential neuroprotective strategies against tauopathy.
Wheeler JM; Guthrie CR; Kraemer BC
Biochem Soc Trans; 2012 Aug; 40(4):656-60. PubMed ID: 22817711
[TBL] [Abstract][Full Text] [Related]
10. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a tractable C. elegans model of tauopathy.
Russell JC; Lei H; Chaliparambil RK; Fish S; Markiewicz SM; Lee TI; Noori A; Kaeberlein M
Geroscience; 2021 Oct; 43(5):2621-2631. PubMed ID: 34536202
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer's disease.
Sivanantharajah L; Mudher A; Shepherd D
J Neurosci Methods; 2019 May; 319():77-88. PubMed ID: 30633936
[TBL] [Abstract][Full Text] [Related]
14. Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration.
Ding Y; Lei L; Lai C; Tang Z
J Alzheimers Dis; 2019; 69(2):339-353. PubMed ID: 31006683
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rf inhibits human tau proteotoxicity and causes specific LncRNA, miRNA and mRNA expression changes in Caenorhabditis elegans model of tauopathy.
Zhang S; Wang H; Wang J; Jin W; Yan X; Chen X; Wang D; Zhao D; Wang Y; Cong D; Sun L
Eur J Pharmacol; 2022 May; 922():174887. PubMed ID: 35306001
[TBL] [Abstract][Full Text] [Related]
16. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
17. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
18. Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.
Jiang Y; MacNeil LT
Mol Neurodegener; 2023 Nov; 18(1):82. PubMed ID: 37950311
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathogenesis of the Tauopathies.
Götz J; Halliday G; Nisbet RM
Annu Rev Pathol; 2019 Jan; 14():239-261. PubMed ID: 30355155
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic nervous system degeneration in a C. elegans Tau
Choudhary B; Mandelkow E; Mandelkow EM; Pir GJ
Neurobiol Dis; 2018 Sep; 117():189-202. PubMed ID: 29894752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
